Biomimetic Molybdenum Sulfide-Catalyzed Tumor Ferroptosis and Bioimaging

Small. 2023 Apr;19(16):e2207544. doi: 10.1002/smll.202207544. Epub 2023 Jan 22.

Abstract

The chemical generation of singlet oxygen (1 O2 ) by the MoO4 2- -catalyzed disproportionation of hydrogen peroxide (H2 O2 ) has been widely applied in numerous catalytic processes; however, such molybdate ions cannot be administered for redox-based cancer therapeutics. This work reports the albumin-mediated biomimetic synthesis of highly active molybdenum sulfide (denoted MoB) nanocatalysts that mediate the simultaneous generation of 1 O2 and superoxide anion (O2 •- ) from H2 O2 , which is relatively abundant in malignant tumors. The MoB-catalyzed reactive oxygen species (ROS) are able to activate the ferroptosis pathway and cause lipid peroxidation for efficient cancer therapy. Furthermore, for the first time, the catalytic activity of MoB is visualized in situ. Moreover, a catalytic imaging modality based on MoB is developed for specific imaging of inflammation diseases without background interference. Therefore, this study presents a biomimetic strategy toward Mo-based nanocatalysts for ROS-facilitated tumor ferroptosis and catalytic imaging.

Keywords: biomimetic synthesis; catalytic imaging; ferroptosis; nanocatalysts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anions / chemistry
  • Anions / metabolism
  • Biomimetics
  • Catalysis
  • Cell Line, Tumor
  • Ferroptosis*
  • Humans
  • Hydrogen Peroxide / metabolism
  • Neoplasms* / diagnostic imaging
  • Reactive Oxygen Species / metabolism

Substances

  • Hydrogen Peroxide
  • molybdenum disulfide
  • Reactive Oxygen Species
  • Anions